To our knowledge, there is no published data exist regarding the predictive value of PD-L1 expression and TILs for anti PD-1/PD-L1 therapy so far, however similar mechanism was found in breast cancer and CRC as well (Li et al., 2016; Kitano et al., 2017). This evidence concerns the gene CD274 and breast carcinoma.